Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:23 June,2020
Critically ill Covid-19 patients 10 times more likely to develop heart rhythm disorders: Study
WASHINGTON: COVID-19 patients who are admitted to an intensive care unit (ICU) may be ten times more likely than others hospitalised with the viral infection to suffer cardiac arrest or heart rhythm disorders, according to a new study which may help better protect those most vulnerable to the disease.
CMAAO Coronavirus Facts and Myth Buster: Proning
With inputs from Dr Monica Vasudev
World Covid Meter 22nd June - 213 Countries affected
Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15
Relieve Stress by Changing the Interpretation
Stress is the reaction of the body or the mind to the interpretation of a known situation. Stress management, therefore, involves either changing the situation, changing the interpretation or taming the body the yogic way in such a way that stress does not affect the body.
Video of The day
Healthcare News Monitor
Game over for Chinese products in India? Modi government to take this big step soon?
It seems, in the view of recent India-China clash in Galwan Valley, the process for bringing an end to sale of Chinese products in India has begun! According to a report, Modi government has sought product-wise details from industry to curb cheap, low quality imports from China. The government has sought product-wise details of cheap imports, comparison with domestic prices and tax disadvantage, if any, from industry to curb low quality inbound shipments especially from China to boost domestic manufacturing, a report by news agency PTI said quoting sources. They said a high level meeting to discuss ways to promote Atma Nirbhar Bharat (Self-reliant India), including cut in import dependence from China, also took place recently in the Prime Minister's office.
Glenmark Pharma zooms 28% on launch of Favipiravir, a potential Covid drug
Shares of Glenmark Pharmaceuticals rallied 40 per cent to Rs 572.7 in the intra-day trade on the BSE on Monday after the company on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 at a price of about Rs 103 per tablet.
Times Now Digital
The COVID-19 crisis has shellshocked the whole world at present. The cases continue to rise in all parts of the world as the deadly virus, which originated from China, remains a dominant force. In India, the metro cities are facing an adverse effect as well due to the outbreak of the COVID-19 crisis.
A doctor of a leading private hospital here has died of COVID-19, sources said on Monday. Sources at Fortis Escorts Heart Institute in Okhla in South Delhi said authorities have been informed about it. More details are awaited.